BiologicsMD™ is a Preclinical Therapeutic Company Focused on Developing Highly-Targeted Parathyroid Hormone Receptor-Mediated Treatments for Hair Loss, Bone Disorders and Oncology.

BiologicsMD is developing a series of patent-protected recombinant fusion proteins, each with 2 functional domains. The first, the Active Domain, provides powerful stimulatory effects at the target receptors and the second, the Binding Domain, localizes the treatment to the point of disease for sustained, targeted, therapeutic exposure with a single, or infrequent, dosing and minimal off-target effects